A Novavax spokesperson said they had data showing their vaccine candidate for the fall aimed at JN.1 has "good cross-reactivity" for KP.2. While Novavax's vaccine takes longer to make than the mRNA shots from Pfizer and Moderna, the spokesperson said FDA's delay to the meeting "will no...
The FLiRT variants have been on the rise in the U.S. and Europe as the coronavirus continues to mutate from earlier strains. KP.2 is now the dominant strain in the U.S., according to the latest data from the Centers for Disease Control and Prevention. LONDON — New strai...
It's possible that even folks who got the latest COVID vaccine aren't well-protected against JN.1 or the FLiRT variants: Onepreprintstudy released this week from researchers at Harvard University suggests waning effectiveness against those strains. That study has not been peer-reviewed, however. ...
COVID omicron vaccine: US reaches deal with Moderna for winter booster shots NIH: COVID-19 booster-induced antibody response to omicron significantly decreases over time 'This is not gone': COVID-19 cases on the rise across Florida Track Florida coronavirus cases by county with this interactive...
Variants KP.2 and KP.3, referred to as FLiRT variants because of specific mutations on their spike proteins, now account for more than 47% of new cases.1 “These variants are descendants of the JN.1 variant, so we expect a vaccine targeted at JN.1 to offer protection against the FLiRT...
“It’s this confluence of a much more infectious variant on top of folks’ overall immunity having waned — either from natural or vaccine-induced immunity,” Hudson said. “It’s just kind of come [as] a perfect storm.” Advertisement ...
were approved for people 12 and older. Moderna’s and Pfizer’s vaccines for kids continue to be available under emergency use authorizations for children six months old through age 11. Novavax is still awaiting an FDA decision on its Covid vaccine. Worth noting here that while the chances ...
In this article, we review the characteristics of the FLiRT variants, including their genetic mutations, epidemiological features, potential impact on public health measures, and implications for vaccine efficacy. We also discuss strategies for surveillance, prevention, and mitigation efforts to control ...
The rates of long COVID dropped over time, regardless of whether people were vaccinated, but the researchers said that was likely due to a combination of changes in the virus and other factors. Overall, the researchers found that the vaccine was responsible for nearly 72% of the drop in cas...
one of the so-calledFLiRT variantsthat have been dominant in the US since May. Those vaccines are for people 6 months and older. A more traditionalprotein vaccine from Novavaxis also available, but it targets JN.1, a variant that is still circulating but less prominently than...